Skip to main content
. 2016 Jul 27;65(11):3418–3428. doi: 10.2337/db16-0234

Table 4.

Manufacturing success rate and results from 75 PHPI lots by facility and for all facilities

Center ID
1 (n = 9) 2 (n = 4) 3 (n = 17) 4 (n = 15) 5 (n = 7) 6 (n = 12) 7 (n = 6) 8 (n = 5) All facilities (N = 75)
All CIT isolations*
 No. lots prepared 57 27 44 39 35 58 19 37 324
 PHPI lots transplanted 29 (50.9) 12 (44.4) 26 (59.1) 22 (56.4) 16 (45.7) 32 (55.2) 17 (89.5) 9 (24.3) 170 (52.5)
Protocol CIT-07
 Donor characteristic
  Age (years) 46 (9) 50 (6) 39 (19) 37 (22) 49 (27) 43 (21) 37 (7) 53 (26) 42 (19)
  Height (cm) 172.0 (5.0) 167.8 (11.6) 182.9 (7.0) 180.0 (12.4) 175.0 (14.9) 175.1 (13.5) 174.4 (9.8) 172.7 (15.3) 177.8 (12.7)
  Weight (kg) 85.0 (28.5) 93.0 (28.1) 113.4 (13.7) 90.7 (28.0) 113.0 (54.9) 112.5 (16.6) 113.6 (29.0) 93.0 (32.0) 107.0 (31.0)
  BMI (kg/m2) 27.1 (7.7) 31.9 (5.6) 34.7 (4.6) 28.2 (11.2) 36.0 (14.8) 36.3 (5.2) 38.4 (12.9) 28.6 (13.6) 33.4 (8.2)
  Cold ischemic time (h) 6.0 (5.4) 8.5 (4.6) 7.4 (2.5) 6.7 (3.2) 7.9 (2.7) 8.9 (5.4) 7.8 (0.7) 7.8 (0.7) 7.7 (3.4)
 Product manufacture
  Final trimmed pancreas weight (g) 95 (37) 93 (46) 109 (28) 103 (40) 101 (63) 102 (64) 112 (31) 124 (19) 106 (40)
  Total packed tissue volume (mL) 45 (6) 45 (5) 44 (14) 45 (30) 40 (46) 39 (18) 25 (1) 40 (10) 44 (16)
  Postdigestion IPN 865,000 (720,723) 718,000 (404,000) 1,183,000 (585,500) 542,000 (556,000) 421,250 (30,500) 351,000 (145,524) 548,500 (231,000) 853,125 (111,250) 537,500 (528,000)
  Postdigestion IEQ 732,250 (128,250) 728,842 (314,642) 1,074,360 (277,000) 693,520 (615,069) 613,534 (447,954) 523,218 (359,927) 787,250 (397,160) 666,068 (93,080) 708,470 (382,000)
  Postdigestion index 1.10 (0.40) 1.00 (0.20) 0.95 (0.15) 1.30 (0.10) 1.30 (0.30) 1.70 (1.40) 1.55 (0.10) 0.70 (0.00) 1.20 (0.60)
  Postpurification IPN 451,750 (188,000) 362,000 (177,000) 506,000 (243,500) 368,250 (216,000) 268,750 (188,750) 233,475 (150,900) 350,750 (205,000) 630,000 (80,000) 390,500 (287,750)
  Postpurification IEQ 620,000 (258,506) 641,275 (273,010) 672,547 (226,290) 556,181 (280,726) 588,602 (338,136) 503,459 (245,830) 569,038 (438,968) 492,736 (96,845) 582,370 (267,931)
  Postpurification index 1.40 (0.50) 1.70 (0.90) 1.30 (0.40) 1.50 (0.50) 1.90 (0.70) 1.95 (0.85) 1.75 (0.70) 0.90 (0.30) 1.50 (0.60)
  Postculture IPN 396,000 (186,000) 242,688 (115,188) 265,250 (180,750) 282,000 (145,750) 197,000 (197,095) 219,250 (103,500) 210,500 (81,690) 484,000 (223,510) 276,000 (171,000)
  Postculture IEQ 469,400 (120,380) 579,915 (139,065) 637,280 (243,020) 455,098 (235,652) 402,600 (168,601) 422,665 (284,797) 598,874 (168,600) 370,034 (43,550) 490,174 (226,835)
  Postculture (index) 1.40 (0.50) 1.55 (0.60) 1.30 (0.90) 1.30 (0.40) 1.30 (0.40) 1.85 (0.90) 1.90 (0.40) 0.80 (0.20) 1.40 (0.70)
 Process recovery (IEQ/g trimmed pancreas)
  Postdigestion 8,135 (2,300) 6,531 (3,812) 8,958 (2,876) 6,270 (4,417) 5,708 (2,919) 4,720 (2,042) 7,778 (3,064) 6,422 (1,527) 6,813 (3,672)
  Postpurification 5,877 (4,544) 5,715 (3,029) 6,601 (1,883) 5,884 (3,942) 5,442 (1,594) 4,634 (1,614) 6,201 (3,501) 4,371 (1,160) 5,471 (2,709)
  Postculture 4,925 (2,730) 5,235 (1,845) 5,749 (1,273) 5,305 (2,614) 4,525 (1,565) 4,064 (662) 5,662 (2,427) 3,319 (1,154) 4,730 (2,156)
 Process yield (%)
  Postpurification 73 (24) 84 (6) 77 (19) 81 (25) 106 (42) 92 (31) 84 (11) 79 (13) 82 (22)
  Postculture 81 (17) 82 (17) 91 (13) 88 (11) 80 (27) 89 (20) 96 (30) 75 (8) 86 (17)
  Overall 61 (25) 71 (13) 68 (17) 71 (20) 73 (25) 85 (39) 79 (7) 60 (12) 71 (22)
 Final product release test results
  GSIR index (high-purity islets, preculture) 2.1 (0.7) 1.6 (1.7) 3.5 (3.9) 2.3 (1.2) 2.9 (3.7) 2.1 (2.0) 2.6 (2.9) 2.0 (0.2) 2.1 (2.0)
  GSIR index (high-purity islets, postculture) 2.6 (0.4) 3.8 (2.7) 2.2 (1.1) 1.6 (1.1) 2.9 (2.4) 1.7 (1.8) 2.2 (1.2) 2.5 (0.7) 2.3 (1.6)
  Settled tissue volume (mL) 5.0 (1.5) 3.9 (1.7) 6.0 (4.2) 3.0 (4.0) 2.9 (2.6) 2.5 (1.1) 3.9 (3.4) 2.2 (0.8) 4.0 (3.8)
  Total transplant (IEQ) 462,510 (119,531) 573,116 (169,216) 614,578 (190,868) 467,135 (245,378) 396,926 (166,745) 406,982 (281,925) 573,643 (178,843) 366,390 (49,896) 480,500 (231,139)
  Islet quantity dose/batch (IEQ/kg recipient BW) 6,535 (1,390) 8,387 (2,943) 7,813 (2,416) 6,561 (3,338) 5,924 (2,267) 6,359 (1,903) 9,035 (1,518) 5,277 (1,892) 6,694 (2,800)
  Viability bag #1 97.00 (6.20) 93.10 (7.50) 89.80 (7.70) 93.00 (1.00) 96.24 (2.32) 94.11 (3.48) 100.00 (0.00) 96.60 (4.90) 93.80 (6.34)
  Endotoxins (EU/kg recipient BW) 0.07 (0.05) 0.58 (0.38) 0.66 (0.72) 0.12 (0.54) 0.02 (0.06) 1.14 (1.53) 3.41 (1.89) 0.88 (0.20) 0.44 (0.86)
  Islet concentration total (IEQ/mL total settled tissue volume) 78,512 (31,467) 155,391 (141,985) 89,580 (105,652) 173,613 (101,180) 134,813 (188,556) 210,443 (178,965) 146,832 (131,407) 218,409 (110,943) 134,813 (131,407)
  Gram stain All negative All negative All negative All negative All negative All negative All negative All negative All negative
Sterility
 Negative 7 (77.8) 4 (100) 16 (94.1) 15 (100) 7 (100) 11 (91.7) 4 (66.7) 5 (100) 69 (92)
 Positive 2 (22.2) 1 (5.9) 1 (8.3) 2 (33.3) 6 (8)
PHPI calculated microscopic purity (%) 70 (3) 63 (20) 66 (14) 60 (15) 57 (27) 75 (32) 70 (32) 80 (13) 69 (17)

Data are n (%) or median (IQR). EU, endotoxin units; IPN, islet particle number.

*The total number of lots includes Center 9, which did not manufacture PHPI for Protocol CIT-07.

†Postdigestion index: IPN values were available for 41 of 75 lots.

‡GSIR preculture result was for information only and not used for lot release.